同型半胱氨酸在肝病诊断中的临床价值研究

摘要

Objective To study the clinical value of Homocysteine in the diagnosis of liver diseases. Methods March 2009 -2011 in September into the hospital for treatment of liver disease in patients with 180 cases, divided into group A (control group, according to the specific sub-type of the patients with liver disease contrast group), group B1(liver cancer group), B2(hepatic cirrhosis group), B3(big three positive group), B4(small three positive group), 45 cases in each group, homocysteine levels were measured in five groups of objects, and compare the measurement results. Results Homocysteine levels in All liver disease of group B was higher than the contrast group, The difference between the Each group and the contrast group had statistically significant meaning in liver diseases detection data. Conclusion The diagnosis of homocysteine levels are closely linked with liver disease,and to provide references for clinical diagnosis and treatment of liver disease with high clinical value.%　　目的研究同型半胱氨酸(Hcy)在肝病诊断中的临床价值.方法选取2009年3月-2011年9月间入我院进行治疗的肝病患者180例，根据患者肝病具体分型分为A组(对照组)、B1组(肝癌组)、B2组(肝硬化组)、B3组(大三阳组)、B4组(小三阳组)，每组45例，对五组对象进行Hcy水平测定，并比较测定结果.结果 B组所有患者Hcy水平均呈现异常升高现象，对照组与各组肝病患者检测数据存在明显差异，具有统计学意义(P <0.05)，结论 Hcy水平同肝脏疾患的诊断有着密切联系，对于肝病的临床诊断和治疗提供了依据，具有较高的临床应用价值.